Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer
Table 2
Perioperative results.
Synchronous combined surgery () (35.7%)
Synchronous “bowel first” () (20%)
Metachronous () (44.3%)
Total ()
value
Colorectal surgery
Technique (, %)
0.006
Open
15 (60%)
5 (35.7%)
7 (22.6%)
40 (57.1%)
Minimally invasive
5 (20%)
9 (64.3%)
17 (54.8%)
31 (44.3%)
Converted
5 (20%)
0
7 (22.6%)
12 (17.1%)
Peritoneal resection (, %)
2 (8%)
1 (7.1%)
2 (6.4%)
5 (7.1%)
1.00
Liver surgery
ASA (, %)
0.522
1
3 (12%)
1 (7.1%)
2 (6.4%)
6 (8.6%)
2
7 (28%)
4 (28.6%)
11 (35.5%)
22 (31.4%)
3
11 (44%)
6 (42.9%)
17 (54.8%)
34 (48.6%)
4
4 (16%)
3 (21.4%)
1 (3.2)
8 (11.4)
Type of surgery (, %)
0.024
Minor/wedge
22 (88%)
7 (50%)
17 (54.8%)
46 (65.7%)
Major
3 (12%)
4 (28.6%)
10 (32.3%)
17 (24.3%)
RFA
0
3 (21.4%)
4 (12.9%)
7 (10%)
Surgery duration (min, range)
300 (170–145)
242.5 (175–369)
230 (50–315)
255 (50–450)
<0.0001
Complications (CD III-IV) (, %)
3 (12%)
3 (21.4%)
4 (12.9%)
10 (14.3%)
0.743
CHT after liver surgery (, %)
18 (72%)
4 (28.6%)
17 (54.8%)
39 (55.7%)
0.032
ASA = American Society of Anesthesiologists; Minor/wedge = minor hepatectomies/hepatic wedge resections; Major = major hepatectomies; RFA = radiofrequency ablation; CD III-IV = Clavien-Dindo classification grade III-IV; CHT = chemotherapy.
